Acquiring Gilead Sciences as a Proposed Strategy for Merck & Co. Growth

Derek Haacker (), Cory Nolan () and Venkatachalam Seshan ()
Additional contact information
Derek Haacker: Pepperdine University
Cory Nolan: Pepperdine University
Venkatachalam Seshan: Pepperdine University

A chapter in Emerging Dimensions of Technology Management, 2013, pp 185-200 from Springer

Abstract: Abstract Merck & Co., a global top ten pharmaceutical company with net sales of $27.4 billion and $13 billion in net income in 2009, controls 4.8 % of the United States market share and 3.39 % of the global pharmaceutical market share (Anon (2011e) Merck 10-K [Online] (Updated 11 February 2011) Available at: http://www.mergentonline.com.lib.pepperdine.edu . Accessed 11 Feb 2011). Through extensive environmental industry analysis and company assessment, the expansion of research and development through the acquisition of biotechnical research Gilead Sciences is a strategy for corporate growth. Gilead is a viable candidate for Merck possessing access to increasingly profitable biotechnology and pipeline presence in the cardiovascular and central nervous market segments. Merck can increase market share and develop new products that reinforce “building and sustaining high performance organizations in a challenging environment.”

Keywords: Market Share; Cash Flow; Market Segment; Central Nervous System Drug; Product Pipeline (search for similar items in EconPapers)
Date: 2013
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-81-322-0792-4_15

Ordering information: This item can be ordered from
http://www.springer.com/9788132207924

DOI: 10.1007/978-81-322-0792-4_15

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().